Studio nicolucci EN
6 months of treatment with Gdue favorly affect
all components of Metabolic Syndrome
This is demonstrated by a major new real-life study* over 505 patients
* "Effectiveness of Ascophyllum nodosum and Fucus vesiculosus on Metabolic Syndrome Components: A Real-World, Observational Study"
Journal of Diabetes Research – September 2021 - Antonio Nicolucci, Maria Chiara Rossi e Massimiliano Petrelli
Slide
Crucial support for maintaining
normal blood sugar levels
Gdue is the first nutraceutical used to control carbohydrate absorption
that shows a favourable effect on all conditions of the Metabolic Syndrome.
Slide
Blood sugar and weight gain are
risk factors for many serious diseases
Keep them under control,
calculate your Body Mass Index!
Slide
Treatment with Gdue favourably affects
all conditions of the Metabolic Syndrome
Numerous scientific studies show a
reduction in Cardiovascular Risk of 27.7%
Slide
Slower carbohydrate absorption
thanks to two brown algae and chromium picolinate
Gdue is more complete than other enzyme inhibitors
used in treatments and prevention
previous arrow
next arrow

THE EFFECTIVE NUTRACEUTICAL ALLY

A DECISIVE SUPPORT FOR PEOPLE SUFFERING FROM OVERWEIGHT, OBESITY, DYSGLYCAEMIA, DIABETES AND CARDIOVASCULAR RISK (METABOLIC SYNDROME)

THE EFFECTIVE NUTRACEUTICAL ALLY

A DECISIVE SUPPORT FOR PEOPLE SUFFERING FROM OVERWEIGHT, OBESITY, DYSGLYCAEMIA, DIABETES AND CARDIOVASCULAR RISK (METABOLIC SYNDROME)

THE EFFECTIVE NUTRACEUTICAL ALLY

A DECISIVE SUPPORT FOR PEOPLE SUFFERING FROM OVERWEIGHT, OBESITY, DYSGLYCAEMIA, DIABETES AND CARDIOVASCULAR RISK (METABOLIC SYNDROME)

What is Gdue?

Gdue is a nutraceutical product containing a phytocomplex extracted from Ascophyllum Nodosum and Fucus Vesiculosus titrated at 20% polyphenols and Chromium Picolinate.

Thanks to Chromium and Ascophyllum Nodosum and Fucus Vesiculosus, Gdue contributes to maintaining normal blood sugar levels and balancing body weight.

1 CAPSULE BEFORE MAIN MEALS
(2/3 CAPSULES/DAY)
REDUCES POSTPRANDIAL BLOOD GLUCOSE
DOES NOT INDUCE HYPOGLYCAEMIA
NO SIDE EFFECTS
GLUTEN FREE

What is Gdue?

Gdue is a nutraceutical product containing a phytocomplex extracted from Ascophyllum Nodosum and Fucus Vesiculosus titrated at 20% polyphenols and Chromium Picolinate.

Thanks to Chromium and Ascophyllum Nodosum and Fucus Vesiculosus, Gdue contributes to maintaining normal blood sugar levels and balancing body weight.

  • REDUCES POSTPRANDIAL BLOOD GLUCOSE

  • DOES NOT INDUCE HYPOGLYCAEMIA

  • NO SIDE EFFECTS
  • GLUTEN FREE

High postprandial blood glucose level is the first sign that physiological control mechanisms are beginning to be altered and, thus, the first step towards:

  • ALTERATION OF THE VARIOUS CONDITIONS OF THE METABOLIC SYNDROME
    (weight, hypertension, hypercholesterolemia, hypertriglyceridemia, insulin resistance)

  • INCREASED CARDIOVASCULAR RISK
  • DIABETES AND ITS COMPLICATIONS

High postprandial blood glucose level is the first sign that physiological control mechanisms are beginning to be altered and, thus, the first step towards:

– ALTERATION OF THE VARIOUS CONDITIONS OF THE METABOLIC SYNDROME
(weight, hypertension, hypercholesterolemia, hypertriglyceridemia, insulin resistance)

– INCREASED CARDIOVASCULAR RISK

– DIABETES AND ITS COMPLICATIONS

Why is Gdue your effective ally

It is a key dietary support for people suffering from overweight, obesity, dysglycaemia, diabetes and cardiovascular risk

A MAJOR NEW REAL-LIFE STUDY* OVER 505 SUBJECTS HAS SHOWN THAT 6 MONTHS OF TREATMENT WITH GDUE HAS A FAVOURABLE IMPACT ON ALL THE CONDITIONS OF THE METABOLIC SYNDROME.

*”Effectiveness of Ascophyllum nodosum and Fucus vesiculosus on Metabolic Syndrome Components: A Real-World, Observational Study” • Antonio Nicolucci, Maria Chiara Rossi e Massimiliano Petrelli
Journal of Diabetes Research – September 2021

Reduction of Cardiovascular Risk by 27.7%

due to action on the following parameters:

  • -7.3Kg
    WEIGHT REDUCTION
  • -7.5cm
    WAIST CIRCUMFERENCE REDUCTION
  • -0,55%
    HbA1c REDUCTION
  • -16,3 mg/dL
    FASTING BLOOD SUGAR REDUCTION
  • -18,2 mg/dL
    LDL REDUCTION
  • +2,9 mg/dL
    HDL INCREASE
  • -39 mg/dL
    TRIGLYCERIDES REDUCTION
  • -7,1 mmHg
    SYSTOLIC BLOOD PRESSURE REDUCTION
  • -4,2 mmHg
    DIASTOLIC BLOOD PRESSURE REDUCTION
Reduction of Cardiovascular Risk by 27.7%

due to action on the following parameters:

  • -7.3Kg WEIGHT REDUCTION
  • -7.5cm WAIST CIRCUMFERENCE REDUCTION
  • -0,55% HbA1c REDUCTION
  • -16,3 mg/dL FASTING BLOOD SUGAR REDUCTION
  • -18,2 mg/dL LDL REDUCTION
  • +2,9 mg/dL HDL INCREASE
  • -39 mg/dL TRIGLYCERIDES REDUCTION
  • -7,1 mmHg SYSTOLIC BLOOD PRESSURE REDUCTION

  • -4,2 mmHg DIASTOLIC BLOOD PRESSURE REDUCTION

News